Global Recombinant Proteins Market Growth (Status and Outlook) 2023-2029

Global Recombinant Proteins Market Growth (Status and Outlook) 2023-2029

Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
LPI (LP Information)' newest research report, the “Recombinant Proteins Industry Forecast” looks at past sales and reviews total world Recombinant Proteins sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Proteins sales for 2023 through 2029. With Recombinant Proteins sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Proteins industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Proteins landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Proteins portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Proteins market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Proteins and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Proteins.
The global Recombinant Proteins market size is projected to grow from US$ 703.8 million in 2022 to US$ 1237.9 million in 2029; it is expected to grow at a CAGR of 8.4% from 2023 to 2029.
Abcam PLC was the largest company in the global Recombinant Proteins market, with a revenue market share of 13% in 2018.

Top 5 companies occupied 40% of the market.

By region, Europe was the biggest region, with a revenue market share over 33%, and North America ranked 2. Asia-Pacific ranked 3, and its market grew fastest.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Proteins market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Segmentation by application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abcam PLC
R&D Systems
Miltenyi Biotec
Thermo Fisher Scientific
Sigma Aldrich Company
GE Healthcare
Lonza
Merck KGaA
ProSpec Tany TechnoGene
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
GenScript Biotech Corporation
Abnova Corporation

Please note: The report will take approximately 2 business days to prepare and deliver.